Search
for

    Sort by

    Research 61–90 of 1000+

    1. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    2. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    3. Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies World Journal of Urology · 2014 · 14 citations
    4. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    5. Alcohol and Prostate Cancer: Time to Draw Conclusions Biomolecules · 2022 · 9 citations
    6. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study Journal of Clinical Medicine · 2022 · 6 citations
    7. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    8. Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS Archivio italiano di urologia, andrologia · 2013 · 4 citations
    9. Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial The Journal of Urology · 2021 · 3 citations
    10. Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma Journal of endourology case reports · 2019 · 3 citations
    11. Phytotherapy in Benign Prostatic Hyperplasia Elsevier eBooks · 2018 · 3 citations
    12. Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS 2019 · 2 citations
    13. PD19-08 MARIJUANA, ALCOHOL, ED AND DEPRESSION: EPIDEMIOLOGIC CORRELATIONS WITH BPH/LUTS 2019 · 1 citations
    14. Editorial comment The Journal of Urology · 2005 · 1 citations
    15. The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them? MAEDICA – a Journal of Clinical Medicine · 2025
    16. The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH. PubMed · 2022
    17. Особливості перебігу симптомів нижніх сечових шляхів у чоловіків із доброякісною гіперплазією передміхурової залози та COVID-19 The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · 2021
    18. AB40. Sexual side effects of medical treatment of BPH PubMed Central · 2014
    19. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    20. Efficacy and safety of long-term administration of tamsulosin hydrochloride in patients with LUTS suggestive of BPH Zhonghua miniao waike zazhi · 2010
    21. S170 DOES STATINS HAVE ANY IMPACT ON THE PROGRESSION OF BPH AND LUTS WHEN COMBINED WITH FINASTERIDE European Urology Supplements · 2010
    22. MP13-07 FINASTERIDE MONOTHERAPY BEFORE TURP: SIGNIFICANT IMPROVEMENT IN EARLY POSTOPERATIVE QUALITY OF LIFE The Journal of Urology · 2017
    23. 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS The Journal of Urology · 2013
    24. Relación entre los síntomas del tracto urinario bajo y las características anatómicas de la próstata en pacientes con obesidad y obesidad grave Cirugía y cirujanos · 2020
    25. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    26. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    27. Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis? 2018 · 11 citations
    28. WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH Therapeutic advances in urology · 2019 · 3 citations
    29. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature Archivio Italiano di Urologia e Andrologia · 2020 · 14 citations
    30. How Many Drugs for LUTS Due to BPH are Too Many? The Journal of Urology · 2008 · 5 citations